Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

Biophytis Files up to $14.95m US IPO at Nasdaq with SEC (2021-01-20)
Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related disease...
Thermo to Acquire PoC MDx Firm Mesa Biotech for up to $550m (2021-01-19)
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under th...
CoviCept Receives $2.3m Seed Investment from Forbion (2021-01-19)
Proceeds used to develop small molecule inhibitor of SARS-CoV-2 and other RNA viruses Forbion, a leading European life sciences venture capital firm, today announces a $2.3m seed investment in newly formed CoviCept Therapeutics, Inc. (“CoviCept”), a California...
T-Knife GmbH Appoints CEO and CBO/CFO (2021-01-19)
T-knife GmbH, a next-generation adoptive T-cell therapy company leveraging its proprietary humanized T-cell receptor (HuTCR) mouse platform to treat solid tumors, today announced the appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. Landis ...
Thermo Acquires Viral Vector Business from Novasep for €725m (2021-01-15)
Expanded global capacity addresses growing demand for cell and gene therapy Thermo Fisher Scientific Inc., (NYSE: TMO), the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading supplier of services and technologies for the life sciences...
NewAmsterdam Pharma Completes €160m Series A Round (2021-01-14)
> Founding investor Forbion joined by co-lead investors, Morningside Ventures and Ascendant BioCapital, and other leaders in global biopharmaceutical investment > Funding will support initiation and finalization of Phase 3 development of obicetrapib, a potent A...
Novartis Licenses Tislelizumab from BeiGene, $650m Upfront (2021-01-11)
> Agreement expands Novartis Oncology portfolio, adding late-stage PD-1 for monotherapy and potential proprietary PD-1 combinations, driving mid- and long-term growth > Novartis secures development and commercialization rights in North America, Europe, and Japan...
Immunocore: $75m Series C Round & $100m Loan Facility (2021-01-11)
Funding follows positive Phase 3 trial interim analysis data for tebentafusp in patients with metastatic uveal melanoma Immunocore, a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapi...
Affimed: up to $25m in Term Loans from SVB (2021-01-11)
€10 million available at closing and up to €15 million available upon achievement of certain milestones Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announce...
Boehringer & Google: Quantum Computing for Pharma R&D (2021-01-11)
> Quantum computing offers the potential to significantly accelerate and optimize the discovery of future new medicines for patients > Scientists from both companies will be breaking new ground in the application of quantum computing to molecular dynamics simula...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

» Start here with the latest News!

Picture [iito] No Content Marketing 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]